Experimental and clinical studies have shown that the early stages of tumorigenesis in HER2-overexpressing breast cancer cells are associated with increased activation of the FASN-mediated synthesis of palmitic acid, which is often used to form lipid rafts [1–3, 5, 15, 19, 41, 42]. Here, FASN is linked to breast cancer.